chloroquine has been researched along with deferoxamine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.29) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Gehrke, SS; Hider, RC; Pinto, EG; Pleban, K; Steverding, D; Tempone, AG; Wagner, GK | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bai, R; Jiang, X; Xie, Y; Zhou, T | 1 |
| Bienzle, U; Chaves, MF; Kremsner, PG; Neifer, S; Rudolph, R | 1 |
| Avramovici-Grisaru, S; Iheanacho, EN; Samuni, A; Sarel, S; Spira, DT | 1 |
| Carnevale, P; Desfontaine, M; Elion, J; Kaptue-Noche, L; Labie, D; M'Bede, J; Nagel, RL; Traore, O | 1 |
| Beug, H; Birnstiel, ML; Cotten, M; Kirlappos, H; Längle-Rouault, F; Mechtler, K; Wagner, E; Zenke, M | 1 |
| Larricart, P | 1 |
| Gekker, G; Keane, WF; Peterson, PK; Schlievert, PM | 1 |
| Farber, JL; Gilbertson, JD; Starke, PE | 1 |
| Deppe, WM; Joubert, SM; Shanley, BC; Stewart-Wynne, EG; Taljaard, JJ | 1 |
| Thompson, DF | 1 |
| Brunner, G; Deepe, GS; Gootee, L; Newman, SL | 1 |
| Basco, LK; Le Bras, J | 1 |
| Dailly, E; Tillement, JP; Urien, S | 1 |
| Bubendorf, A; Dorn, A; Ridley, RG; Vennerstrom, JL; Vippagunta, SR | 1 |
| Crichton, RR; Josse, C; Legssyer, R; Piette, J; Ward, RJ | 1 |
| Garner, P; Omari, A | 1 |
| Köstler, E; Wollina, U | 1 |
| Kidane, TZ; Linder, MC; Sauble, E | 1 |
| Aurizi, C; Barbieri, L; Biolcati, G; Lupia Palmieri, G; Macrì, A | 1 |
| Mullié, C; Sonnet, P | 1 |
| Fujita, H; Fukuhara, H; Furihata, M; Inoue, K; Kurabayashi, A; Sasaki, J; Shuin, T; Utsumi, K | 1 |
| Fan, G; Feng, L; Fu, Y; Hao, H; He, Y; He, Z; Hu, X; Liu, Z; Shen, P; Wang, Y; Wu, J; Zhang, N; Zhu, K | 1 |
5 review(s) available for chloroquine and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.
Topics: Animals; Humans; Iron Chelating Agents; Iron Overload; Pyridones | 2020 |
Deferoxamine treatment of malaria.
Topics: Animals; Chloroquine; Clinical Trials as Topic; Deferoxamine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum | 1994 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Therapy of porphyria cutanea tarda.
Topics: Chloroquine; Deferoxamine; Erythropoietin; Humans; Iron; Phlebotomy; Porphyria Cutanea Tarda; Renal Dialysis; Sunscreening Agents | 2005 |
1 trial(s) available for chloroquine and deferoxamine
| Article | Year |
|---|---|
Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria.
Topics: Animals; Chloroquine; Deferoxamine; Drug Therapy, Combination; Humans; Malaria; Parasite Egg Count; Plasmodium falciparum | 1991 |
22 other study(ies) available for chloroquine and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators.
Topics: Aminoquinolines; Antiprotozoal Agents; Deferiprone; Dose-Response Relationship, Drug; Iron Chelating Agents; Leishmania infantum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridones; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.
Topics: Animals; Arginine; Chloroquine; Deferoxamine; Female; Immunization; Interferon-gamma; Liver; Malaria; Mice; Mice, Inbred BALB C; omega-N-Methylarginine; Pentoxifylline; Tumor Necrosis Factor-alpha | 1992 |
Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
Topics: Animals; Antimalarials; Chloroquine; Deferoxamine; Drug Resistance; Electron Spin Resonance Spectroscopy; Hydrazines; Iron; Iron Chelating Agents; Molecular Structure; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Spectrophotometry | 1991 |
Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels.
Topics: Chloroquine; Cobalt; Deferoxamine; Heptanoates; Humans; In Vitro Techniques; Luciferases; Monensin; Phagocytosis; Polylysine; Porphobilinogen Synthase; Receptors, Transferrin; Transferrin; Transformation, Genetic; Tumor Cells, Cultured | 1990 |
[Retinal diseases].
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Antipsychotic Agents; Canthaxanthin; Carotenoids; Chloroquine; Contraceptives, Oral; Deferoxamine; Digitalis Glycosides; Epinephrine; Humans; Indomethacin; Macula Lutea; Miotics; Phenothiazines; Quinine; Retinal Diseases | 1985 |
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bacterial Toxins; Cell Separation; Cell Survival; Chloroquine; Deferoxamine; Endocytosis; Endotoxins; Enterotoxins; Hydroxides; In Vitro Techniques; Kidney Tubules; Lipid A; Lipopolysaccharides; Male; Methylamines; Necrosis; Rats; Rats, Inbred Strains; Superantigens; Thiourea | 1986 |
Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide.
Topics: Animals; Cell Survival; Chloroquine; Deferoxamine; Ferric Compounds; Hydrogen Peroxide; Hydrogen-Ion Concentration; In Vitro Techniques; Iron; Liver; Lysosomes; Male; Methylamines; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1985 |
Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
Topics: Adult; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chloroquine; Deferoxamine; Humans; Iron; Liver; Male; Middle Aged; Porphyrias; Porphyrins; Rats; Recurrence | 1972 |
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.
Topics: Animals; Cells, Cultured; Chloroquine; Deferoxamine; Ferric Compounds; Histoplasma; Histoplasmosis; Humans; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitrilotriacetic Acid; Transferrin | 1994 |
In vitro activity of chloroquine and quinine in combination with desferrioxamine against Plasmodium falciparum.
Topics: Animals; Anti-Bacterial Agents; Chloroquine; Deferoxamine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Plasmodium falciparum; Quinine | 1993 |
Chain-breaking antioxidants and ferriheme-bound drugs are synergistic inhibitors of erythrocyte membrane peroxidation.
Topics: Adult; Amidines; Antioxidants; Ascorbic Acid; Chloroquine; Deferoxamine; Drug Synergism; Erythrocyte Membrane; Fatty Acids; Female; Hemin; Humans; Linoleic Acid; Lipid Peroxidation; Male; Membrane Lipids; Oxidation-Reduction; Oxygen Consumption; Oxyhemoglobins; Probucol; Pyridines; Reperfusion Injury; Vitamin E | 1998 |
Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine.
Topics: Animals; Antimalarials; Biopolymers; Chelating Agents; Chloroquine; Deferoxamine; Drug Interactions; Hemin; Hydrogen-Ion Concentration; Plasmodium falciparum; Solubility | 1999 |
Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine.
Topics: Animals; Chloroquine; Deferoxamine; Iron; Liver; Macrophages, Alveolar; Male; Nitric Oxide; Rats; Rats, Wistar; Spleen | 2003 |
Release of iron from ferritin requires lysosomal activity.
Topics: Animals; Caco-2 Cells; Chloroquine; Deferoxamine; Enterocytes; Erythroid Cells; Ferritins; Hepatocytes; Humans; Immunoelectrophoresis; Iron; K562 Cells; Leupeptins; Lysosomes; Oligopeptides; Peptide Hydrolases; Protease Inhibitors; Rats | 2006 |
Association between porphyria cutanea tarda and beta-thalassemia major.
Topics: Adult; Anemia; beta-Thalassemia; Chloroquine; Deferoxamine; Female; Hepatitis C; Humans; Iron Overload; Middle Aged; Porphyria Cutanea Tarda; Porphyrins; Siderophores | 2009 |
In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin.
Topics: Antimalarials; Benzoates; Chloroquine; Deferasirox; Deferiprone; Deferoxamine; Glutathione; Hemeproteins; Hemin; Hydrogen Peroxide; Inhibitory Concentration 50; Iron Chelating Agents; Plasmodium falciparum; Pyridones; Structure-Activity Relationship; Triazoles; Triterpenes; Ursolic Acid | 2011 |
The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Cell Line, Tumor; Chloroquine; Deferoxamine; Drug Synergism; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins | 2013 |
Cadmium induces liver dysfunction and ferroptosis through the endoplasmic stress-ferritinophagy axis.
Topics: Autophagy; Cadmium; Chloroquine; Deferoxamine; Endoplasmic Reticulum Stress; Ferritins; Ferroptosis; Humans; Iron; Iron Chelating Agents; Liver Diseases | 2022 |